ENDRA Life Sciences Inc.

NASDAQ: NDRA · Real-Time Price · USD
4.53
0.09 (2.03%)
At close: Aug 15, 2025, 10:00 AM

ENDRA Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
211.6K 211.6K 428.41K 428.41K 428.41K 428.41K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
155.92K 211.6K 167.05K 237.5K 260.08K 275.45K 281.97K 270.12K 253.08K 234.26K 220.16K 223.07K 227.76K 224.41K 170.75K 109.24K 48.87K
Gross Profit
55.68K n/a 261.36K 190.91K 168.32K 152.96K -281.97K -270.12K -253.08K -234.26K -220.16K -223.07K -227.76K -224.41K -170.75K -109.24K -48.87K
Operating Income
-8.04M -10.82M -7.98M -9.6M -10.36M -10.52M -12.38M -12.66M -13.24M -13.16M -12.92M -12.15M -11.78M -11.5M -10.68M -11.29M -10.98M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-9.77M -11.51M -8.82M -9.57M -9.89M -10.06M -11.89M -12.23M -13.26M -13.18M -12.99M -12.21M -11.82M -11.23M -10.38M -10.98M -10.67M
Net Income
-9.77M -11.51M -8.82M -9.57M -9.89M -10.06M -11.87M -12.23M -13.29M -2,858.2B -2,858.2B -2,858.2B -2,858.2B -11.23M -10.38M -10.98M -10.67M
Selling & General & Admin
6.83M 7.63M 4.85M 5.63M 5.71M 5.52M 6.29M 6.38M 6.51M 6.6M 6.6M 6.49M 6.22M 6.02M 5.48M 5.49M 5.44M
Research & Development
2.68M 3.19M 3.13M 3.97M 4.65M 5M 6.09M 6.29M 6.73M 6.55M 6.31M 5.66M 5.55M 5.48M 5.2M 5.8M 5.54M
Other Expenses
n/a 4.84K 3.08K 31.31K 468.74K 460.49K 486.03K 434.79K -22.02K -21.53K -78.41K -62.9K -42.44K -41.55K -4.88K 9.00 188.00
Operating Expenses
9.51M 10.76M 7.86M 9.48M 10.25M 10.46M 12.38M 12.66M 13.24M 13.16M 12.92M 12.15M 11.78M 11.5M 10.68M 11.29M 10.98M
Interest Expense
n/a n/a n/a n/a n/a 3.42K 3.42K 26.43K 45.8K 2,858.2B 2,858.2B 2,858.2B 2,858.2B n/a n/a n/a 3.86K
Selling & Marketing Expenses
401.37K 571.04K 632.6K 792.78K 877.6K 820.55K 999.49K 1.18M 1.27M 1.43M 1.48M 1.34M 1.25M 1.08M 885.69K 749.87K 627.87K
Cost & Expenses
8.2M 10.98M 7.98M 9.6M 10.36M 10.52M 12.38M 12.66M 13.24M 13.16M 12.92M 12.15M 11.78M 11.5M 10.68M 11.29M 10.98M
Income Tax Expense
n/a 4.00 7.00 7.00 7.00 3.42K -20.37K 2.64K 22.02K 2,858.2B 2,858.2B 2,858.2B 2,858.2B -6.42K -2.84K 4.67K 8.7K
Shares Outstanding (Basic)
557.58K 536.91K 1.12M 1.71M 1.71M 1.71M 1.71M 1.71M 1.93M 1.93M 1.93M 1.93M 2.15M 2.1M 2.1M 2.08M 1.89M
Shares Outstanding (Diluted)
557.58K 536.91K 1.12M 1.71M 1.71M 1.71M 1.71M 1.71M 1.93M 1.93M 1.93M 1.93M 2.15M 2.1M 2.1M 2.08M 1.89M
EPS (Basic)
-13 -12.77 -5.89 -5.61 -5.8 -5.7 -6.54 -6.51 -6.88 -1.33M -1.33M -1.33M -1.33M -5.49 -5.89 -7.35 -9.74
EPS (Diluted)
-13 -12.77 -5.89 -5.61 -5.8 -5.7 -6.54 -6.51 -6.88 -1.33M -1.33M -1.33M -1.33M -5.49 -5.89 -7.35 -9.74
EBITDA
-7.93M -10.65M -7.79M -9.33M -10.11M -10.26M -12.08M -12.43M -13.01M -12.94M -12.77M -11.99M -11.59M -11.33M -10.48M -11.14M -10.85M
EBIT
-7.89M -10.67M -7.98M -9.6M -10.36M -10.52M -12.38M -12.66M -13.24M -13.16M -12.95M -12.18M -11.81M -11.53M -10.68M -11.28M -10.97M
Depreciation & Amortization
150.5K 206.17K 221.06K 237.5K 260.08K 275.45K 281.97K 270.12K 253.08K 234.26K 220.16K 223.07K 227.76K 224.41K 242.02K 198.28K 176.62K